Functional variations in gamma‐secretase processing of APP are critical determinants of the clinical, biomarker, and cognitive progression of autosomal dominant Alzheimer's disease.

MLA

Schultz, Stephanie A., et al. “Functional Variations in Gamma‐secretase Processing of APP Are Critical Determinants of the Clinical, Biomarker, and Cognitive Progression of Autosomal Dominant Alzheimer’s Disease.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 19, Dec. 2023, pp. 1–3. EBSCOhost, https://doi.org/10.1002/alz.082318.

APA

Schultz, S. A., Liu, L., Schultz, A. P., Fitzpatrick, C. D., Levin, R., Bellier, J., Shirzadi, Z., Joseph, M. N., Chen, C. D., Benzinger, T. L. S., Day, G. S., Farlow, M. R., Hassenstab, J. J., Jack, C. R., Jucker, M., Lee, J., Levin, J., Perrin, R. J., Schofield, P. W., & Karch, C. M. (2023). Functional variations in gamma‐secretase processing of APP are critical determinants of the clinical, biomarker, and cognitive progression of autosomal dominant Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 19, 1–3. https://doi.org/10.1002/alz.082318

Chicago

Schultz, Stephanie A., Lei Liu, Aaron P. Schultz, Colleen D Fitzpatrick, Raina Levin, Jean‐Pierre Bellier, Zahra Shirzadi, et al. 2023. “Functional Variations in Gamma‐secretase Processing of APP Are Critical Determinants of the Clinical, Biomarker, and Cognitive Progression of Autosomal Dominant Alzheimer’s Disease.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 19 (December): 1–3. doi:10.1002/alz.082318.